BRISTOL MYERS SQUIBB COMPANY UNA CORPORACION DEL ESTADO DE DELAWARE has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in Uruguay. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PF MEDICAMENT, ONO FARMASYUTIKAL KO LTD and PHARMA MAR SAU.
# | Country | Total Patents | |
---|---|---|---|
#1 | Uruguay | 25 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Steroids | |
#7 | Analysing materials | |
#8 | Acyclic or carbocyclic compounds | |
#9 | Organic chemistry methods | |
#10 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Meanwell Nicholas A | 4 |
#2 | Makonen Belema | 3 |
#3 | Kadow John F | 3 |
#4 | Lopez Omar D | 3 |
#5 | Ray Camphausen | 2 |
#6 | Bender John A | 2 |
#7 | Regueiro-Ren Alicia | 2 |
#8 | Pothukanuri Srinivasu | 2 |
#9 | Kandhasamy Sarkunam | 2 |
#10 | Cload Sharon T | 2 |
Publication | Filing date | Title |
---|---|---|
UY36749A | AMINOPIRIDINE COMPOUNDS REPLACED WITH HETEROARILO AS QUINASE INHIBITORS AND IRAK-4 MODULATORS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |